What is the average impact of lyrica therapy on drowsiness?

How Common Is Drowsiness with Lyrica?

Lyrica (pregabalin) causes drowsiness or somnolence in 13-36% of patients across clinical trials, depending on dose and condition treated, compared to 4-11% on placebo.[1] This side effect is dose-dependent, rising from about 13% at 150 mg/day to 36% at 600 mg/day for neuropathic pain.

What Do Clinical Studies Show for Average Impact?

In pooled data from 38 double-blind trials (n=7,000+ patients):
- Somnolence incidence: 22% overall (vs. 7% placebo).
- Led to discontinuation in 3-6% of users.
- Severity is typically mild to moderate; severe cases are rare (<2%).[1][2]

For specific uses:
| Condition | Drowsiness Rate (Lyrica) | Placebo Rate |
|-----------|---------------------------|--------------|
| Fibromyalgia | 22-39% | 7-12% |
| Diabetic neuropathy | 20-33% | 5-8% |
| Postherpetic neuralgia | 19-28% | 6-10% |
| Epilepsy (adjunct) | 25-36% | 11% |[1][3]

How Long Does Drowsiness Last and Does It Fade?

Onset occurs within 1-2 weeks; it peaks early then often decreases with continued use (tolerance develops in ~50% of cases by week 4).[2] Average duration: 2-4 weeks at full intensity, resolving or lessening in most without stopping therapy.

Factors Affecting Drowsiness Severity

• Dose: Higher doses (300-600 mg/day) double the risk vs. low doses.
  
• Age: Elderly patients experience it 20-30% more often.
  
• Combinations: Risk jumps with opioids (up to 50%) or benzodiazepines due to CNS depression.[3]
  
• Individual variation: Women and those with renal impairment report higher rates.
  
  

Managing Drowsiness on Lyrica

Start at low dose (75-150 mg/day) and titrate slowly over 1 week to minimize impact. Taking at bedtime reduces daytime effects. Avoid alcohol and driving until tolerated. If persistent, dose reduction or switching to gabapentin (similar but sometimes less sedating) helps 60-70% of cases.[3]

[1]: Lyrica Prescribing Information (Pfizer)
[2]: FDA Label Analysis
[3]: Clinical Pharmacology Review